Currus Biologics Company

Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
Technology: CAR-T
Industry: Private
Headquarters: Melbourne, Victoria, Australia
Founded Date: 2020-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 2
Total Funding: 10000000
Last Funding Date: 2021-06-29
Last Funding Type: Series A

Visit Website
info@currusbio.com
Register and Claim Ownership